Biohit and Ympyrätalo Pharmacy to co-operation
Biohit Oyj Press Release January 29, 2015 at 11:30 am local time (EET)
Biohit Oyj and Ympyrätalo Pharmacy (Helsinki, Finland) have agreed to co-operate thereby Ympyrätalo Pharmacy will offer diagnostic tests by Biohit to its customers. Co-operation covers Biohit’s tests for diagnosis of digestinal diseases. Ympyrätalo Pharmacy provides nursing services and the tests as a part of its permanent base range.
GastroPanel® is a non-invasive gastric health test which reveals whether the gastric mucosa is healthy or not. The test diagnoses H. pylori infection and atrophic gastritis, caused by H. pylori of autoimmune disease. These results can be used to assess whether patients have risk of gastric or esophagus cancer, peptic ulcer disease or risk of vitamin B12, calcium or iron deficiency and what further examinations and treatment is needed.
Active vitamin B12 test allows the diagnosis of B12 vitamin deficiency from blood sample. Vitamin B12 deficiency can occur in seemingly healthy people, and the risk increases with age. The test does not measure the level of total B12, but it measures the available active form of vitamin B12, holotranscobalamin, level in the blood.
ColonView is a diagnostic quick test for early detection, screening and diagnostics of the risk of colorectal cancer (colon cancer). This sensitive test detects fecal occult blood derived from both the upper and lower gastrointestinal tract - with improved sensitivity for even small benign lesions (polyps) and cancer precursors (adenomas).
Calprotectin test enables the differentiation of inflammatory bowel disease IBD and irritable bowel syndrome (IBS) as well as monitoring of inflammatory bowel disease.
The Celiac Quick test will bring clear benefits in healthcare costs, because it reduces the number of unnecessary endoscopies.ä.
Pharmacist Tiina Vaitomaa, Ympyrätalo Pharmacy: ‘We are introducing a new business model in which the pharmacy’s basic range also includes nursing services and diagnostics tests. The new service will be emphasized, for example, in regular customers’ annual health check-ups.’
CEO Semi Korpela, Biohit Oyj: ‘The resale of diagnostic tests is suitable for pharmacy business and Ympyrätalo Pharmacy is an active pioneer in this field.’
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Pharmacist Tiina Vaitomaa, Ympyrätalo Pharmacy
tel. +358 29 340 0685
tiina.vaitomaa@ympyrätalonapteekki.fi
www.ympyratalonapteekki.fi
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
Ympyrätalo Pharmacy in brief
Ympyrätalo Pharmacy, located in Hakaniemi Helsinki, offers a new kind of servioce that is based on the customer’s needs. Service and product range is unique for its scope. Our goal is to motivate customers to take care of herself and also offer preventive health and wellness services. www.ympyratalonapteekki.fi